B형 간염 건강 보균자인 노인에서 장기간 저용량 Methotrexate (MTX) 투약으로 발생한 간 경변증 1예

키워드

참고문헌 (21)

1. Bologna C, "Long-term follow-up of 453 rheumatoid arthritis patients treated with methotrexate: an open, retrospective, observational study", Br J Rheumatol, (36), pp.535~540 (1997)
2. Kremer JM, "Safety, efficacy, and mortality in a long-term cohort of patients with rheumatoid arthritis taking methotrexate: follow up after a mean of 13.3 years.", Arthritis Rheum, (40), pp.984~985 (1997)
3. Drosos AA, "Influence of methotrexate on radiographic progression in rheumatoid arthritis: a sixty-month prospective study", Clin Exp Rheumatol, (15), pp.263~267 (1997)
4. Mikuls TR, "The changing face of rheumatoid arthritis therapy: results of serial surveys.", Arthritis Rheum, (43), pp.464~465 (2000)
5. Shergy WJ, "Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.", Am J Med, 85(6), pp.771~774 (1988)
6. Lanse SB, "Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk", benefit ratio., 1985, pp.30(2), 104~109
7. Ito S, "Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient", Arthritis Rheum, 44(2), pp.339~342 (2001)
8. Hagiyama H, "Fulminant hepatitis in an asymptomatic chronic carrier of hepatitis B virus mutant after withdrawal of low-dose methotrexate therapy for rheumatoid arthritis.", Clin Exp Rheumatol, 22(3), pp.375~376 (2004)
9. Morgan SL, "Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial.", Ann Intern Med, (121), pp.833~841 (1994)
10. Morgan SL, "The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis", Arthritis Rheum, (33), pp.9~18 (1990)
11. Kremer JM, "Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples.", Arthritis Rheum, (32), pp.121~127 (1989)
12. Zachariae H, "Methotrexate-induced liver cirrhosis. Clinical, histological and serological studies-a further 10-year follow-up.", Dermatology, 192(4), pp.343~346 (1996)
13. Kremer JM, "Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology.", Arthritis Rheum, (37), pp.316~328 (1994)
14. Roenigk HH Jr, "Methotrexate and liver biopsies. Is it really necessary?", Arch Intern Med, 150(4), pp.733~734 (1990)
15. Gilbert SC, "Methotrexate-induced cirrhosis requiring liver transplantation in three patients with psoriasis. A word of caution in light of the expanding use of this ‘steroid-sparing’ agent.", Arch Intern Med, 150(4), pp.889~891 (1990)
16. Weinstein A, "Low-dose methotrexate treatment of rheumatoid arthritis. Long-term observations", Am J Med, 79(3), pp.331~337 (1985)
17. Shergy WJ, "Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.", Am J Med, 85(6), pp.771~774 (1988)
18. Iwai K, "Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period.", Bone Marrow Transplant, 25(1), pp.105~108 (2000)
19. Clark FL, "uccessful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma.", Ann Oncol, 9(4), pp.385~387 (1998)
20. 박용욱, "HBsAg 양성 및 음성인 류마티스 관절염 환자에서 Methotrexate의 간독성 비교", 대한내과학회 추계학술대회 (2001)
21. Xiao WB, "Elevation of serum and ascites cancer antigen 125 levels in patients with liver cirrhosis.", J Gastroenterol Hepatol, 18(11), pp.1315~1316 (2003)

관련 논문AI추천